Synergistic chemodynamic and metabolic reprogramming-based cancer therapy by CuO@HA nanozymes with oxygen vacancy
Theranostics · 2026
DOI: 10.7150/thno.119806 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Weiwei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China. Hauptthemen laut MEDLINE: Copper, Hyaluronic Acid, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.
- Qilu University of Technology (Shandong Academy of Sciences), Shandong Analysis and Test Center, Jinan, Shandong 250014, China.
- Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 03760, Republic of Korea.
- Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Republic of Korea.
Zitieren
APA
Wang, W., Cai, Y., Wang, Z., Song, H., Hu, T., Jia, Y., Feng, M., Yoon, J., Hu, Q., & Wang, Y. (2026). Synergistic chemodynamic and metabolic reprogramming-based cancer therapy by CuO@HA nanozymes with oxygen vacancy. Theranostics. https://doi.org/10.7150/thno.119806
Vancouver
Wang W, Cai Y, Wang Z, Song H, Hu T, Jia Y, et al. Synergistic chemodynamic and metabolic reprogramming-based cancer therapy by CuO@HA nanozymes with oxygen vacancy. Theranostics. 2026. doi:10.7150/thno.119806
BibTeX
@article{Wang2026,
author = {Wang, Weiwei and Cai, Yuxuan and Wang, Zhongxing and Song, Haoyang and Hu, Tangbin and Jia, Ying and Feng, Maoxiao and Yoon, Juyoung and Hu, Qiongzheng and Wang, Yunshan},
title = {Synergistic chemodynamic and metabolic reprogramming-based cancer therapy by CuO@HA nanozymes with oxygen vacancy},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.119806}
}
EUVIMED